Unbiased AI-powered news
5 stories related to this topic, newest first.
japantimes.co.jpThe company that sells Amgen’s drug Tavneos in Japan is recommending that doctors stop prescribing the medicine. The action adds to existing regulatory scrutiny of the treatment in multiple countries. Tavneos is approved for use in several markets including the United States.
benzinga.comThe U.S. Food and Drug Administration withdrew several studies concluding that Covid-19 and shingles vaccines had rare serious side effects, according to an HHS spokesperson. The studies, funded by taxpayer money, analyzed millions of patient records. FDA officials cited unsuppor…
Washington ExaminerCongress included a provision in 2025 funding legislation limiting hemp-derived THC to 0.4 milligrams per container, effective November 2026. President Donald Trump urged lawmakers to amend the measure to preserve access to CBD products. The policy has drawn responses from indust…
Substrate placeholder — needs reviewA pharmaceutical company has introduced insulin at a $35 monthly price cap for certain patients. Studies provide additional evidence on the safety of abortion medications for over-the-counter use. These updates form part of broader health news coverage.
Substrate placeholder — needs reviewSynthetic peptides are increasingly used by individuals for enhancing strength, energy, recovery, and libido, often purchased from unregulated sources. These compounds lack FDA approval and human clinical data, raising risks of contamination and unknown effects. Investigations re…